Continence 40 mg/ml Syrup for Dogs

País: Reino Unido

Idioma: inglés

Fuente: VMD (Veterinary Medicines Directorate)

Ingredientes activos:

Phenylpropanolamine

Disponible desde:

Support Pharma S.L.

Código ATC:

QG04BX91

Designación común internacional (DCI):

Phenylpropanolamine

formulario farmacéutico:

Syrup

tipo de receta:

POM-V - Prescription Only Medicine – Veterinarian

Grupo terapéutico:

Dogs

Área terapéutica:

Neurological Agent

Estado de Autorización:

Authorized

Fecha de autorización:

2019-08-09

Ficha técnica

Revised: September 2019
AN: 00957/2019
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
CONTINENCE 40 mg/ml syrup for dogs
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
1 ml contains:
ACTIVE SUBSTANCE:
Phenylpropanolamine…………………………………………40.28
mg
equivalent to phenylpropanolamine hydrochloride………...50 mg
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Syrup.
Clear colourless to pale yellow solution.
4.
CLINICAL PARTICULARS
4.1.
TARGET SPECIES
Dogs
4.2.
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the management of urinary incontinence associated with urethral
sphincter
incompetence in the bitch, particularly that associated with
ovariohysterectomy.
4.3.
CONTRAINDICATIONS
Do not administer to patients treated with non-selective monoamine
oxidase
inhibitors.
Do not use in cases of known hypersensitivity to the active substance
or to any of the
excipients.
Do not administer to pregnant or lactating bitches.
4.4.
SPECIAL WARNINGS FOR EACH TARGET SPECIES
The product should be avoided in hypertensive individuals.
In bitches less than 1 year old the possibility of anatomical
disorders contributing to
incontinence should be considered prior to treatment.
The use of the product is not appropriate for the treatment of
behavioural causes of
inappropriate urination.
Page 1 of 6
Revised: September 2019
AN: 00957/2019
4.5.
SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
Phenylpropanolamine, a sympathomimetic drug, may affect the
cardiovascular
system, especially blood pressure and heart rate, and should be used
with caution in
animals with cardiovascular diseases.
Care should be exercised in treating animals with severe renal or
hepatic
insufficiency, diabetes mellitus, hyperadrenocorticism, glaucoma,
hyperthyroidism or
other metabolic disorders.
Special precautions to be taken by the person administering the
veterinary medicinal
product to animals
Phenylpropanolamine hydrochloride is toxic when overdoses are